Distribuzione geografica
Continente #
NA - Nord America 9942
EU - Europa 8938
AS - Asia 6518
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 7
OC - Oceania 4
Totale 25458
Nazione #
US - Stati Uniti d'America 9835
CN - Cina 6482
IE - Irlanda 2911
UA - Ucraina 2005
DE - Germania 1103
SE - Svezia 867
FI - Finlandia 802
IT - Italia 589
GB - Regno Unito 385
FR - Francia 145
CA - Canada 106
BE - Belgio 46
MU - Mauritius 31
RU - Federazione Russa 30
NL - Olanda 29
EU - Europa 17
IR - Iran 16
IN - India 12
ES - Italia 10
AU - Australia 4
CL - Cile 4
HU - Ungheria 4
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
DK - Danimarca 2
GR - Grecia 2
IQ - Iraq 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CO - Colombia 1
ID - Indonesia 1
LU - Lussemburgo 1
LV - Lettonia 1
MX - Messico 1
SA - Arabia Saudita 1
TR - Turchia 1
VN - Vietnam 1
Totale 25458
Città #
Dublin 2911
Chandler 2644
Jacksonville 2587
Nanjing 2096
Nanchang 850
Princeton 640
Lawrence 603
Shenyang 593
Hebei 571
Wilmington 559
Changsha 558
Jiaxing 510
Medford 408
Tianjin 324
Hangzhou 310
Beijing 280
Boardman 268
Ann Arbor 195
Woodbridge 148
Milan 120
Verona 111
Norwalk 110
Helsinki 92
Fairfield 61
Toronto 58
Kunming 54
Houston 53
Mcallen 52
Pavia 50
Des Moines 47
Falls Church 42
Brussels 41
Munich 39
Montréal 37
Ningbo 35
Zhengzhou 34
Jinan 33
Dearborn 23
Fuzhou 22
Lanzhou 19
Orange 18
Guangzhou 17
San Genesio Ed Uniti 17
Taizhou 16
Changchun 15
Rome 15
Berlin 14
Los Angeles 14
Ashburn 13
Auburn Hills 13
Borås 13
Shanghai 11
Chieti 10
Pescara 8
Redwood City 8
Rochester 8
Catanzaro 7
Madrid 7
San Francisco 7
Monmouth Junction 5
Mountain View 5
Napoli 5
Padova 5
Palermo 5
Saint Petersburg 5
Saint-herblain 5
Tübingen 5
Walnut 5
Bari 4
Florence 4
Frankfurt am Main 4
Hefei 4
Jinhua 4
Legnaro 4
Leuven 4
Melbourne 4
Rockville 4
Szeged 4
Washington 4
Zanjan 4
Ardabil 3
Ferrara 3
Haikou 3
Kansas City 3
Kemerovo 3
Las Vegas 3
Novokuznetsk 3
Nutley 3
Orzinuovi 3
Qingdao 3
Sacramento 3
Seregno 3
Torino 3
Andover 2
Barletta 2
Benevento 2
Bologna 2
Centro 2
Clearwater 2
Copenhagen 2
Totale 18565
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 215
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 204
Calcio antagonisti e aritmie da riperfusione miocardica 126
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 88
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 84
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 83
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 82
[Sympathetic reflex induced by experimental coronary occlusion]. 81
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 78
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 76
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 75
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 75
FGF12 is a candidate Brugada syndrome locus. 74
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 73
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 73
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 72
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 70
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 69
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 69
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 69
Alpha 1-adrenergic blockade and sudden cardiac death. 67
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 67
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 67
Mortalità infantile e morte improvvisa in culla in Lombardia 66
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 65
Sertraline treatment of major depression in patients with acute MI or unstable angina. 65
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 65
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 64
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 64
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 63
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 62
Adrenergic Arrhythmogenesis and The Long QT syndrome 62
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 62
A sympathetic reflex elicited by experimental coronary occlusion. 62
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 61
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. 61
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 61
Task Force Report: The legal implications of medical guidelines - a Task Force of the European Society of Cardiology 60
The ICD for the long QT syndrome: which indications, complications, and results? 60
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 60
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 60
All LQT3 patients need an ICD. True or false? 59
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 59
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)]. 59
Cardiac sodium channel dysfunction in sudden infant death syndrome. 59
QT prolongation and sudden infant death syndrome - from theory to evidence. 59
Prevalence of the congenital long-QT syndrome. 59
Two-to-one AV block associated with the congenital QT syndrome 58
Cost effectiveness of neonatal ECG screening for the long QT syndrome: reply. 58
The quest for the mechanism of the sudden infant death syndrome. Doubts and progress 58
Nuovi rischi medico-legali per il cardiologo: la cardiologia molecolare ed il caso della sindrome del QT lungo. 58
Inherited cardiac arrhythmia syndrome. Role of potassium channels 58
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 58
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 58
An experimental approach to the choice of antiarrhythmic therapy. 58
Cardiac potassium channel dysfunction in sudden infant death syndrome. 58
Multiple mechanisms of Na+ channel--linked long-QT syndrome. 58
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes 57
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 57
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 57
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease. 57
The long QT syndrome. Prospective longitudinal study of 328 families. 57
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 57
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 57
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 57
Risk stratification in the Long-QT Syndrome 56
The RecordAF Study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation 56
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 56
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 56
Gene symbol: SCN5A 55
Gene symbol: KCNH2. 55
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 55
Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. 55
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? 55
The long QT syndrome: a clinical counterpart of hERG mutations. 55
Can a message from the dead save lives? 55
Vagal stimulation for heart failure 55
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 55
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 55
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 55
A cardiac murmur depending on the Wolff-Parkinson-White syndrome. 55
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 54
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 54
Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. 54
Effect of stellectomy and vagotomy on ventricular refractoriness in dogs. 54
[Infant mortality and sudden crib death in Lombardy]. 54
Low penetrance in the long-QT syndrome: clinical impact. 54
Significance of Qt dispersion in the long QT syndrome 53
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 53
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 53
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias 53
Progress in the evaluation of a new class I antiarrhythmic agent: Penticainide 53
Unilateral stellectomy and dysrhythmias. 53
ATRAMI: a mark in the quest for the prognostic value of autonomic markers. Autonomic Tone and Reflexes After Myocardial Infarction. 53
Cardiac arrhythmias in infancy: prevalence, significance and need for treatment. 53
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 53
Genetic testing for the long QT syndrome: who and why? Insights for clinical management. 53
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 53
Heart rate profile during exercise as a predictor of sudden death. 53
Totale 6456
Categoria #
all - tutte 50714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50714

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018285 0000 00 00 02283027
2018/20191880 241168939 3012 51117 443231863
2019/20208063 237935029387 8432 28451 1355326239
2020/20213657 437345108376 36486 11569 117560503109
2021/20222401 31107228 34176 30129 173673901261
2022/20237750 92145558608 836888 11460 3513000
Totale 25729